[HTML][HTML] The closely related rare and severe acute myeloid leukemias carrying EVI1 or PRDM16 rearrangements share singular biological features
M Eveillard, J Delaunay, S Richebourg, L Lodé… - …, 2015 - ncbi.nlm.nih.gov
M Eveillard, J Delaunay, S Richebourg, L Lodé, R Garand, S Wuillème, F Duhoux…
haematologica, 2015•ncbi.nlm.nih.gov2. Yamazaki H, Suzuki M, Otsuki A, et al. A remote GATA2 hematopoietic enhancer drives
leukemogenesis in inv (3)(q21; q26) by activating EVI1 expression. Cancer Cell. 2014; 25
(4): 415-427. 3. Gröschel S, Lugthart S, Schlenk RF, et al. High EVI1 expression predicts
outcome in younger adult patients with acute myeloid leukemia and is associated with
distinct cytogenetic abnormalities. J Clin Oncol. 2010; 28 (12): 2101-2107. 4. Grimwade D,
Hills RK, Moorman A, et al. Refinement of cytogenetic classification in acute myeloid …
leukemogenesis in inv (3)(q21; q26) by activating EVI1 expression. Cancer Cell. 2014; 25
(4): 415-427. 3. Gröschel S, Lugthart S, Schlenk RF, et al. High EVI1 expression predicts
outcome in younger adult patients with acute myeloid leukemia and is associated with
distinct cytogenetic abnormalities. J Clin Oncol. 2010; 28 (12): 2101-2107. 4. Grimwade D,
Hills RK, Moorman A, et al. Refinement of cytogenetic classification in acute myeloid …
2. Yamazaki H, Suzuki M, Otsuki A, et al. A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv (3)(q21; q26) by activating EVI1 expression. Cancer Cell. 2014; 25 (4): 415-427. 3. Gröschel S, Lugthart S, Schlenk RF, et al. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities. J Clin Oncol. 2010; 28 (12): 2101-2107. 4. Grimwade D, Hills RK, Moorman A, et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood. 2010; 116 (3): 354-365. 5. Rogers HJ, Vardiman JW, Anastasi J, et al. Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv (3)(q21q26. 2)/t (3; 3)(q21; q26. 2): a Bone Marrow Pathology Group study. Haematologica 2014; 99 (5): 821-829. 6. Lugthart S, Gröschel S, Beverloo H, et al. Clinical, molecular, and prognostic significance of WHO type inv (3)(q21q26. 2)/t (3; 3)(q21; q26. 2) and various other 3q abnormalities in acute myeloid leukemia. J Clin Oncol. 2010; 28 (24): 3890-3898. 7. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008.
ncbi.nlm.nih.gov